• 1
    Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501509.
  • 2
    Rubin PC. Hypertension in pregnancy. J Hypertens 1987; 5 (Suppl 3): S57S60.
  • 3
    Terragno NA, Terrdgno A. Mechanism of hypertension in preg nancy. Semin Nephrol 1988; 8: 138146.
  • 4
    Brinkman 111 CR. Maternal cardiovascular and renal disorders—biologic adaptation to pregnancy. In: CreasyRK, ResnickR, editors. Maternal-Fetal Medicine: Principles and Practice. WB, Saunders: Philadelphia, 1984: 679691.
  • 5
    Talledo OE, Chesley LC, Zuspan FP. Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol 1968; 100: 218221.
  • 6
    Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PCA study of angiotensin II pressor responses throughout primigravid pregnancy. J Clin Invest 1913; 52:26822689.
  • 7
    Remuzzi G, Ruggenenti P. Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years Am J Kidney Dis 1991; 18:285305.
  • 8
    Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152:335340.
  • 9
    Hunyor SN. Hemodynamics in pregnancy and in pregnancy hyper tension. In: ZanchettiA, TaraziRC, editors. Handbook of Hypertension, Pathophysiology of Hypertension: Cardiovascular Aspects. Vol 7. Amsterdam : Elsevier Science Publishers, 1986: 298310.
  • 10
    Roberts JM, Taylor RM, Golfein A. Clinical and biochemical evidence of endothelial cell disfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4: 700708.
  • 11
    Lunell NO, Nylund LE, Lewander R. Uteroplacental blood flow in preeclampsia. Measurements with indium-113m and a com puter-linked gamma camera. Clin Exp Hypertens 1982; B11: 101110.
  • 12
    Weiner CP. The clinical spectrum of preeclampsia. Am J Kidney Dis 1987; 4: 312316.
  • 13
    Sjoberg T, Andersson KE, Norgren L, Steen S. Comparative effects of some calcium-channel blockers on human peripheral arteries and veins. Acta Physiol Scand 1987; 130:419427.
  • 14
    Luscher TF, Yang Z, Kiowski W, Linder L, Dohi Y, Diederich D. Endothelin-induced vasoconstriction and calcium antagonists. J Hum Hypertens 1992; 6 (Suppl 2): S3S8.
  • 15
    Kiowski W, Luscher TF, Linder L, Buhler FR. Endothelin-l-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991, 83: 469475.
  • 16
    Forman A, Andersson KE, Maigaard S. Effects of calcium chanell blockers on the female genital tract. Ada Pharmacol Toxicol 1986; 58 (Suppl 2): 183192.
  • 17
    Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892898.
  • 18
    Soares-da-Silva P. Preferential decarboxylation of L-threo-3, 4-dihydroxiphenylserine in rat renal tissues. Gen Pharmacol 1993; 24:7581.
  • 19
    Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunorreactivity in liver disease and the hepatorrenal syndrome. N Engl J Med 1992; 327: 17741778.
  • 20
    Amenta F, Collier WL, Ricci A. Autoradiographic localization of vascular dopamine receptors. Am J Hypertens 1990; 3: 34 S36 S.
  • 21
    Amenta F, Coppola L, Gallo P, Ferrante F. Monopoli A, Napoleone P Autoradiographic localization of D-adrenergic receptors in human large coronary arteries. Circ Res 1991; 68: 15911599.
  • 22
    Amenta F, Ferrante F, Ferreira-de-Almeida JA, Ricci A, Pereira-Leite L. Pharmacological characterization and autoradiographic localization of neurotransmitter receptors in umbilical vessels. In: CosmiEV, RenzoGC, editors. Hypertension in Pregnancy. Bologna : Monduzzi Editore, 1991: 105108.
  • 23
    De Lean A, Hancock AA, Lefkowitz RJ. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 1982; 2: 59.
  • 24
    Cheng YC, Prusoff WH. Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC-50) of an enzymatic reaction. Biochem Pharmacol 1973; 22 30993108.
  • 25
    Young WS, Kuhar MJ. A new method for receptor autoradiography: (3H)-opioid receptors in rat brain. Brain Res 1979; 199: 255270.
  • 26
    De Michele M, Amenta F, Cavallotti C. Autoradiographic localization of muscarinic receptors within the rat kidney. Eur J Pharmacol 1989; 169:297305.
  • 27
    Borges N, Polonia J. Use of spreadsheet for statistical and graphical processing of records from the ambulatory blood pressure monitor Spacelabs 90207. Rev Port Cardiol 1993; 12: 313319.
  • 28
    Pederson EB, Rarmussen AB, Christensen NJ. Plasma noradrena-line and adrenaline in preeclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol 1982; 99:594600.
  • 29
    Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension [letter]. N Engl J Med 1990; 323: 14861487.
  • 30
    Polonia J, Ferreira-de-Almeida J, Matias A et al. Renin-angiotensin aldosterone, sympathetic and endothelin systems in normal and hypertensive pregnancy: response to postural and volume load stimuli. J Hypertens 1993; 11 (Suppl 5): 82428243.
  • 31
    Boarder MR, Marriot DB. Characterization of endothelin-l stimulation of catecholamine release from adrenal chromafin cells / Cardiovasc Pharmacol 1989; 13 (Suppl 5): S223S224.
  • 32
    Rasmussen H. The calcium messenger system. N Engl J Med 1986; 314: 10941100.
  • 33
    Robinson BF, Dobbs RJ, Kelsey CR The effects of nifedipine on the resistance vessels, arteries and veins in man. Br J Clin Pharmacol 1980; 10:433438.
  • 34
    Dostal DE, Murahashi T, Peach MJ Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 1990; 15: 815822.
  • 35
    Erne P, Bolli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: effects of antihypertensive therapy. N Engl J Med 1984; 130:10841088.
  • 36
    Kilby MD, Broughton Pipkin F, Symonds EM. Calcium and platelets in normotensive and hypertensive human pregnancy. J Hypertens 1992; 10:9971003.
  • 37
    Barr SM, Lees KR, Butters L, ODonnell A, Rubin PC. Platelet intracellular free calcium concentration in normotensive and hypertensive pregnancies in the human. Clin Sci 1989; 76: 6771.
  • 38
    Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublin-gual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol 1988; 5: 12761281.
  • 39
    Wide-Swensson D, Ingemarsson I, Andersson KE, Anandakumar C, Arulkumaran S, Ratnam SS. lsradipine reduces blood pressure, but not placental blood flow in pregancy-induced hypertension. Clin Exp Hypertens 1991; B10: 4960.
  • 40
    Baker PN, Kilby MD, Broughton Pipkin F. The effect of angiotensin 11 on platelet intracellular free calcium concentration in human pregancy. J Hyperfens 1992; 10: 5540.
  • 41
    Triggle DJ. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am J Hypertens 1991; 4422 S4429 S.
  • 42
    Ebata H, Natsume T, Mitsuhashi T, Yaginuma T. Reduced calcium sensitivity of dihydropyridine binding to calcium channels in spontaneously hypertensive rats. Hypertension 1991; 17:234241.